# Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

> **NCT07486401** · NA · RECRUITING · sponsor: **National Healthcare Group Polyclinics** · enrollment: 240 (estimated)

## Conditions studied

- Asthma Exacerbations
- Biomarkers / Blood
- Eosinophil Blood Count

## Interventions

- **DIAGNOSTIC_TEST:** Biomarker-directed treatment for asthma management
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT07486401
- **Lead sponsor:** National Healthcare Group Polyclinics
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-03
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07486401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07486401, "Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07486401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*